Glutaminase inhibitors: a patent review-Reference-Cited by-同舟云学术

Glutaminase inhibitors: a patent review

Published:2018-10-11 Issue:11 Volume:28 Page:823-835
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Wu CanRong¹,Chen LiXia²,Jin Sanshan³,Li Hua¹²

Affiliation:

1. Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

2. Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, China

3. Maternal and Child Health Hospital of Hubei Province, Wuhan, China

Funder

Fundamental Research Fund for the Central Universities

National Natural Science Foundation of China (NSFC)

Training Program Foundation for the Distinguished Young Scholars of University in Liaoning Province

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2018.1530759

Reference99 articles.